Company Filing History:
16 out of 29 
1 out of 1 Years Active: 2018-2023
Title: The Innovative Mind of Tien-Lan Hsieh: A Trailblazer in Neuropsychiatric Treatments
Introduction: Tien-Lan Hsieh, an accomplished inventor based in New Taipei, Taiwan, has made significant contributions to the field of pharmaceuticals with a focus on treating neuropsychiatric disorders. With a remarkable portfolio of 17 patents, Hsieh's work is at the forefront of innovation, addressing critical health issues through his unique chemical formulations.
Latest Patents: Among his latest patents, Hsieh has developed co-crystals of lithium benzoate and sodium benzoate, both aimed at mitigating the risk for various neuropsychiatric disorders. The co-crystals of lithium benzoate are formulated with a co-former compound and involve methods of preparation that have potential applications in treating conditions such as schizophrenia, psychotic disorders, depressive disorders, bipolar disorders, and neurodegenerative disorders. Similarly, his co-crystals of sodium benzoate are designed to address neuropsychiatric challenges and metabolic disorders, including obesity, diabetes, hypercholesterolemia, hypertension, and hyperlipidemia.
Career Highlights: Over the years, Tien-Lan Hsieh has been affiliated with Syneurx International Corporation and Synenrx International Corporation, where he played an integral role in research and development. His work has been pivotal in advancing the understanding of chemical compounds as therapeutic agents, making significant strides in both academia and the pharmaceutical industry.
Collaborations: Hsieh has collaborated with notable colleagues in his field, including Ching-Cheng Wang and Guochuan Emil Tsai. These partnerships have fostered an environment of creativity and innovation, enabling the exploration and development of new therapeutic solutions.
Conclusion: Tien-Lan Hsieh exemplifies the spirit of innovation through his dedicated research and impactful patents. His contributions not only advance scientific knowledge but also hold promise for improving the lives of individuals affected by various mental health disorders. With each new patent, Hsieh continues to inspire future inventions that could reshape the landscape of neuropsychopharmacology.